Inclusion Criteria:~1. Adult males or females Aged 45 years through 85 years (have not had their 86th
birthday)~2. Men and women with a diagnosis of Alzheimer's disease according to the clinical criteria~3. Women
must be of non-childbearing potential, surgically sterile, or willing to use adequate birth control; men who
are sexually active will also be required to use adequate birth control~4. Able to give consent for
participation on their own or through their Legally Acceptable Representative~5. MRI/CT scan assessment within
six months before baseline, corroborating the clinical diagnosis of AD and excluding other potential causes of
dementia, especially cerebrovascular lesions~6. MMSE score in between 11 to 26 in case of mild to moderate
stage of Alzheimer's disease~6. Absence of major depressive disease according to Geriatric Depression Scale
(GDS) of < 5 7. Previous decline in cognition for more than six months as documented in subject's medical
records 8. Subject, who are on stable treatment with any of AD drugs are also eligible to participate in this
study 9. Formal education for eight or more years 10. Subjects living at home or nursing home setting, without
continuous nursing care 11. General health status acceptable for participation in a 6-months clinical trial 12.
A caregiver available and living in the same household or interacting with the subject a sufficient time each
week and available if necessary to assure administration of drug 13. Subjects with any other chronic conditions
are stable and undergoing appropriate treatment~
